Omda 관리

관리 기준 확인 2/4

Omda CEO는 Sverre Flatby, Jan2008 에 임명되었습니다 의 임기는 16.83 년입니다. 는 NOK 63.33M 가치에 해당하는 회사 주식의 10.06% 직접 소유합니다. 63.33M. 경영진과 이사회의 평균 재임 기간은 각각 8.3 년과 3 년입니다.

주요 정보

Sverre Flatby

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	16.8yrs
CEO 소유권	10.1%
경영진 평균 재임 기간	8.3yrs
이사회 평균 재임 기간	3yrs

최근 관리 업데이트

Recent updates

Improved Revenues Required Before Omda AS (OB:OMDA) Stock's 28% Jump Looks Justified

Mar 24

Fewer Investors Than Expected Jumping On Omda AS (OB:OMDA)

Jan 24

Omda's (OB:OMDA) Earnings May Just Be The Starting Point

Nov 18

Are Investors Undervaluing CSAM Health Group AS (OB:CSAM) By 44%?

Jun 17

CSAM Health Group AS (OB:CSAM) Is About To Turn The Corner

May 11

Here's What CSAM Health Group AS' (OB:CSAM) Shareholder Ownership Structure Looks Like

Feb 14

CSAM Health Group AS' (OB:CSAM) Has Found A Path To Profitability

Jan 10

CEO

Sverre Flatby

16.8yrs

테뉴어

Mr. Sverre Flatby serves as the Group Chief Executive Officer of CSAM Health AS. Mr. Flatby serves as the Chief Executive Officer of Omda AS (formerly known as CSAM Health Group AS) since 2008. In this rol...

리더십 팀

이름	위치	테뉴어	보상	소유권
Sverre Flatby	Chief Executive Officer	16.8yrs	데이터 없음	10.06% NOK 63.3m
Einar Bonnevie	Chief Financial Officer	16.8yrs	데이터 없음	10.06% NOK 63.3m
Leif Buen	Chief Operations Officer	12.8yrs	데이터 없음	데이터 없음
Marius Johansen	Legal Director	3.2yrs	데이터 없음	데이터 없음
Helen Docker	Chief Marketing & Communications Officer	2.7yrs	데이터 없음	데이터 없음
Glenn Bruun	Chief Strategy Officer	16.8yrs	데이터 없음	2.41% NOK 15.2m
Johan Hedensio	Executive Vice President of Emergency	3.8yrs	데이터 없음	데이터 없음
Ilan Eini	Managing Director of Aygo AS	1.8yrs	데이터 없음	데이터 없음

8.3yrs

평균 재임 기간

경험이 풍부한 관리: OMDA 의 관리팀은 노련하고 경험 (평균 재직 기간 8.3 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Gunnar Bjorkavag	Director	3.5yrs	데이터 없음	0.028% NOK 178.2k
Marianne Johnsen	Vice Chairman of the Board	2.5yrs	데이터 없음	데이터 없음
Ase Michelet	Chair of the Board of Directors	4.2yrs	데이터 없음	0.056% NOK 354.2k
Kjellrun Borgmo	Employee Representative Director	no data	데이터 없음	0.024% NOK 151.7k
Hans Robbestad	Director	2.5yrs	데이터 없음	1.13% NOK 7.1m
Daniel Forslund	Director	no data	데이터 없음	데이터 없음

3.0yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: OMDA 의 이사회는 경험(평균 재직 기간 3 년)으로 간주됩니다.

Omda 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Omda AS, Annual General Meeting, Apr 25, 2024

No independent directors

No independent directors

Insider recently bought kr498k worth of stock

CSAM Health Group AS, Annual General Meeting, May 06, 2021

Recent updates

Returns On Capital Are Showing Encouraging Signs At Omda (OB:OMDA)

Consensus EPS estimates have been downgraded.

Consensus EPS estimates have been downgraded.

Consensus EPS estimates increase from loss to kr0.7777 profit, revenue downgraded

Price target decreased by 9.2% to kr44.50

Second quarter 2024 earnings released

Returns At Omda (OB:OMDA) Are On The Way Up

Consensus EPS estimates have been downgraded.

Omda AS (OB:OMDA) commences an Equity Buyback Plan under the authorization approved on April 25, 2024.

Investor sentiment improves as stock rises 19%

Omda's (OB:OMDA) Earnings Are Weaker Than They Seem

First quarter 2024 earnings released

Full year 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase from loss to kr0.449 profit

Improved Revenues Required Before Omda AS (OB:OMDA) Stock's 28% Jump Looks Justified

Price target decreased by 10% to kr49.00

Full year 2023 earnings released: EPS: kr5.04 (vs kr6.28 loss in FY 2022)

Investor sentiment deteriorates as stock falls 20%

New major risk - Share price stability

Fewer Investors Than Expected Jumping On Omda AS (OB:OMDA)

Omda AS, Annual General Meeting, Apr 25, 2024

Consensus EPS estimates have been upgraded.

Omda's (OB:OMDA) Earnings May Just Be The Starting Point

Investor sentiment improves as stock rises 26%

Third quarter 2023 earnings released

No longer forecast to breakeven

Omda AS to Report Q2, 2024 Results on Aug 23, 2024

Forecast to breakeven in 2025

New major risk - Revenue and earnings growth

Forecast to breakeven in 2025

Second quarter 2023 earnings released

Are Investors Undervaluing CSAM Health Group AS (OB:CSAM) By 44%?

Consensus EPS estimates fall by 29%

Price target increased by 8.8% to kr61.50

Full year 2022 earnings released

CSAM Health Group AS (OB:CSAM) commences an Equity Buyback Plan under the authorization approved on May 19, 2022.

Forecast to breakeven in 2025

CSAM Health Group AS to Report Q4, 2022 Results on Feb 28, 2023

Consensus EPS estimates fall by 16%

Third quarter 2022 earnings released

Price target decreased to kr60.50

No independent directors

Consensus EPS estimates fall by 70%

Price target decreased to kr71.00

Second quarter 2022 earnings released

Consensus EPS estimates fall by 60%

Price target decreased to kr97.00

Full year 2021 earnings: EPS misses analyst expectations

No independent directors

Consensus forecasts updated

Price target decreased to kr116

CSAM Health Group AS (OB:CSAM) acquired Carmona AB for SEK 20 million.

Now 28% undervalued after recent price drop

Consensus EPS estimates fall by 10%

Spigraph Sweden Ab acquired Scanner business in Sweden from CSAM Health Group AS (OB:CSAM).

Insider recently bought kr498k worth of stock

Third quarter 2021 earnings: Revenues in line with analyst expectations

No longer forecast to breakeven

Legal & HR Director Marius Johansen has left the company

CSAM Health Group AS (OB:CSAM) entered in an agreement to acquire Medscinet Ab for SEK 24 million.

Forecast breakeven pushed back to 2022

CSAM Health Group AS (OB:CSAM) Is About To Turn The Corner

Revenue misses expectations

Full year 2020 earnings released

CSAM Health Group AS (OB:CSAM) acquired Public Safety business of Carmenta AB for an enterprise value of SEK 150 million.

Here's What CSAM Health Group AS' (OB:CSAM) Shareholder Ownership Structure Looks Like

New 90-day low: kr80.66

CSAM Health Group AS, Annual General Meeting, May 06, 2021

New 90-day high: kr106

CSAM Health Group AS' (OB:CSAM) Has Found A Path To Profitability